Anzeige
Mehr »
Mittwoch, 13.05.2026 - Börsentäglich über 12.000 News
Bahnbrechende KI-Lösung "Ohne Nadelstiche" als Ersatz für herkömmliche Bluttests "unlocked"?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 857675 | ISIN: US0758871091 | Ticker-Symbol: BOX
Tradegate
13.05.26 | 20:20
122,85 Euro
-2,27 % -2,85
Branche
Gesundheitswesen
Aktienmarkt
S&P 500
1-Jahres-Chart
BECTON DICKINSON AND COMPANY Chart 1 Jahr
5-Tage-Chart
BECTON DICKINSON AND COMPANY 5-Tage-Chart
RealtimeGeldBriefZeit
122,85123,1023:00
122,75123,4522:00

Aktuelle News zur BECTON DICKINSON Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoBactiguard Holding AB: Bactiguard and BD strengthen global partnership expanding access to Foley catheters designed to reduce infection risk for patients worldwide168Bactiguard Holding AB (publ) today announces an update to its long standing collaboration with license partner BD (Becton, Dickinson & Company), a leading global medical technology company, through...
► Artikel lesen
BECTON DICKINSON Aktie jetzt für 0€ handeln
DoBECTON DICKINSON & CO - S-8, Securities to be offered to employees in employee benefit plans1
DoBECTON DICKINSON & CO - 10-Q, Quarterly Report2
DoIs the Options Market Predicting a Spike in Becton Dickinson Stock?3
DoBecton Dickinson Hikes Profit Outlook, Names CFO8
DoBecton, Dickinson higher after Q2 beat, guidance boost19
DoBecton Dickinson Q2 FY26 slides: EPS beat drives guidance raise7
DoBD forecasts FY 2026 adjusted EPS of $12.52-$12.72 while reaffirming low-single-digit revenue growth4
DoBecton Dickinson: Starke Q2-Zahlen und angehobene Jahresprognose19
DoBecton, Dickinson And Company Names Vitor Roque CFO349WASHINGTON (dpa-AFX) - Becton, Dickinson and Company (BDX), a medical technology company, announced Thursday that it has appointed Vitor Roque as executive vice president and chief financial...
► Artikel lesen
DoBecton, Dickinson And Company Slips To Loss In Q2, Lifts FY26 Adj. Earnings Outlook337WASHINGTON (dpa-AFX) - Thursday, Becton, Dickinson and Company (BDX) announced its second-quarter financial results, reporting a net loss of $311 million compared with a net income of $308 million...
► Artikel lesen
DoBD names Vitor Roque as chief financial officer3
DoBD (Becton, Dickinson and Company): BD Appoints Vitor Roque Chief Financial Officer264FRANKLIN LAKES, N.J., May 7, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that...
► Artikel lesen
DoBD (Becton, Dickinson and Company): BD Reports Second Quarter Fiscal 2026 Financial Results274Revenue of $4.7 billion increased 5.2% as reported, 2.6% FXN GAAP and adjusted diluted EPS from continuing operations of $(0.13) and $2.90, respectively Executed...
► Artikel lesen
DoBECTON DICKINSON & CO - 8-K, Current Report1
06.05.Becton Dickinson vor Quartalszahlen: Anleger prüfen Wachstumsstrategie nach Spartenverkauf10
04.05.Evercore ISI reinstates Becton Dickinson stock rating at Outperform4
04.05.Evercore ISI stellt Einstufung für Becton Dickinson auf "Outperform" wieder her13
29.04.BD launches new central venous catheter insertion device6
27.04.BD, Suttons Creek Partner to Support Pharma & Biotech Companies Developing Combination Products6
Weiter >>
156 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1